ArticleInternational journal of molecular medicine2022

miR‑4730 suppresses the progression of liver cancer by targeting the high mobility group A1 pathway.

Hirotaka Furuke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.